#None #Webinar #Xtalks #Pediatric Obesity

Addressing Gaps in Pediatric Obesity Trials

In the realm of drug development, pediatric and adolescent obesity trials have solidified their importance, yet substantial evidence gaps still hinder the translation of research findings across various age demographics. The upcoming webinar, hosted by Xtalks, seeks to tackle these challenges through enhanced trial design, laying out a roadmap for addressing the pressing need for evidence-based approaches in this critical field.

The Current Landscape of Pediatric Obesity Research

As we navigate the complexities of obesity in young populations, two significant studies—SCALE Teens and STEP TEENS—have illuminated the potential of GLP-1 receptor agonists in achieving better BMI outcomes among adolescents. However, the existing data remains sparse for children aged 6 to 11, emphasizing the need for meticulous endpoint selection and the interpretation of body composition, particularly during periods of active bone growth and puberty.

Unpacking the Webinar Components

This informative session will delve into various considerations imperative for effective trial design. Notable topics include:

• - Endpoint Selection: Understanding which outcomes are most relevant and reliable for pediatric populations.
• - Biomarker Qualification: Exploring how biomarkers can enhance the understanding of metabolic dysfunction in adolescents and their potential for regulatory acceptance.
• - Retention Strategies: Sharing best practices to minimize dropout rates in pharmacotherapy trials focused on young participants.
• - Regulatory Frameworks: Discussing the implications of current guidelines (such as FDA draft guidance and ICH E11(R1)) on trial interpretations concerning the growth and development of children.

Attendees will gain insights into the importance of defining established methodologies versus those backed by limited evidence. The purpose is to enable sponsors to create robust global pediatric obesity programs. Moreover, engaging with real-world evidence frameworks will foster a deeper understanding of how to tailor research to meet the specific challenges presented by different age cohorts.

Featured Expert Panel

The webinar will feature esteemed panelists including:

• - Dr. Graham C Ellis: Clinical Vice President at Signant Health, who will share his expertise on optimizing clinical trial methodologies for children.
• - Dr. Justin Devine: Co-Founder and Chief Innovation Officer at Synexa Life Sciences, focusing on innovative biomarker strategies.
• - Dr. Shipra Patel: Global TA Section Head for Endocrinology/Metabolism at Parexel, offering insights from a pediatric perspective on regulatory considerations.

Together, these experts will navigate the evolving landscape of pediatric obesity treatments, addressing both current challenges and the strides needed for improving trial outcomes.

Conclusion and Registration Information

As the trend towards leveraging evidence-based practices in obesity trials continues to grow, understanding the nuances of pediatric and adolescent research is crucial. The upcoming webinar aims to equip professionals in the healthcare and biopharmaceutical sectors with actionable insights to bridge these gaps.

For those interested in enhancing their understanding of pediatric obesity trials and strategies to improve evidence generation, registration is open for the webinar slated for Friday, November 6, 2026, at 11 AM EST (5 PM CET). To register and find more information, visit Xtalks - Pediatric & Adolescent Obesity Webinar

Join the conversation and help shape the future of pediatric obesity research.